Given that CEBPA mRNA levels were decreased by about 50% both in human patients and in mice, hepatocyte heterozygous CEBPA-KO (CebpaΔHep,f/+) mice were used to test whether a reduction of CEBPA affected the extent of liver fibrosis. The gene discussed is CEBPA; the disease is Hepatic fibrosis.